Home / Market News / $VSTM
benzinga Corporate Catalyst Impact 55/100 ● negative

Guggenheim Maintains Buy on Verastem, Lowers Price Target to $12

Aug 7, 2026, 4:46 PM UTC · Primary ticker $VSTM

Guggenheim analyst Michael Schmidt reiterated a 'Buy' rating on Verastem but reduced the price target from $14 to $12. This indicates a continued positive outlook on the company's long-term prospects despite a slightly tempered near-term valuation.

Guggenheim analyst Michael Schmidt maintained a 'Buy' rating on Verastem, signaling continued confidence in the company's fundamentals or pipeline. However, the simultaneous reduction of the price target from $14 to $12 suggests a recalibration of near-term expectations or a slight increase in perceived risk. This move affects Verastem directly, as analyst ratings and price targets can influence investor sentiment and short-term stock performance. While the 'Buy' rating offers a positive long-term signal, the lowered price target could lead to some downward pressure or limit upside in the immediate future, creating a mixed signal for traders.

$VSTM negative Price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.